Clinical Trial Update: A Double-Blind Study of E5555 in Japanese Subjects With Coronary Artery Disease [Phase 2]

View source ↗

Summary

Phase 2 double-blind trial update of E5555 in Japanese subjects with coronary artery disease. The study is sponsored by Eisai Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• E5555

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED